Fred G. Weiss's most recent trade in RVL Pharmaceuticals plc was a trade of 5,506 Ordinary Shares done at an average price of $3.3 . Disclosure was reported to the exchange on Aug. 27, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RVL Pharmaceuticals plc | Fred G. Weiss | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.31 per share. | 27 Aug 2021 | 5,506 | 118,466 (0%) | 0% | 3.3 | 18,225 | Ordinary Shares |
| RVL Pharmaceuticals plc | Fred G. Weiss | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2021 | 61,188 | 123,972 (0%) | 0% | 0 | Ordinary Shares | |
| RVL Pharmaceuticals plc | Fred G. Weiss | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.89 per share. | 18 Jun 2021 | 18,584 | 62,784 (0%) | 0% | 2.9 | 53,708 | Ordinary Shares |
| RVL Pharmaceuticals plc | Fred G. Weiss | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.46 per share. | 24 Jan 2021 | 5,505 | 81,368 (0%) | 0% | 4.5 | 24,552 | Ordinary Shares |